Xeris Biopharma Holdings Inc (XERS)

$XERS 90 DAYS STOCK PRICE FORECAST

Stock Price

About the Company

We do not have any company description for Xeris Biopharma Holdings Inc at the moment.

Exchange

NASDAQ

$35M

Total Revenue

180

Employees

$124M

Market Capitalization

-1.36

Price/Earning ratio

Similar Companies

Name Ticker Market Capitalization (USD M) Revenue (USD M) Price/Book Price/Earning Net Margin (%)
Conversion Labs Inc CVLB 108548 35213 3.74 42.66 7.33
Royalty Pharma plc RPRX 21578 2286 2.88 20.15 13.26
Organon & Co. OGN 7323 7878 -4.52 4.82 19.26
Arvinas Inc ARVN 3963 23 4.93 -19.95 -794.96
Tilray Inc TLRY 2976 564 0.99 -7.48 -66.49
Usana Health Sciences Inc USNA 2097 1230 4.87 15.27 11.04
ATAI Life Sciences N.V. ATAI 1782 20 3.94 -10.71 -821.63
Cronos Group Inc CRON 1527 57 0.96 -10.58 -258.59
DICE Therapeutics Inc DICE 1211 1 3.72 -30.64 None
NRX Pharmaceuticals Inc NRXP 1170 2321 0.45 5.05 9.91
Intersect ENT Inc XENT 894 104 56.42 -10.10 -85.02
Ventyx Biosciences Inc VTYX 877 -10.72 -10.48 None
Phibro Animal Health Corp. PAHC 825 853 3.49 16.77 5.70
Edgewise Therapeutics Inc EWTX 793 2.79 -21.86 None
Phathom Pharmaceuticals Inc PHAT 673 5.72 -4.13 None
Theseus Pharmaceuticals Inc THRX 567 -12.12 -26.25 None
Cyteir Therapeutics Inc CYT 548 2.80 -15.36 None
Rani Therapeutics Holdings Inc RANI 514 3 9.84 -25.43 -678.00
Urovant Sciences Ltd UROV 503 -3.65 -3.08 None
Pliant Therapeutics Inc PLRX 475 10 2.16 -5.04 -914.12
Fulcrum Therapeutics Inc FULC 472 18 2.59 -6.30 -409.62
Ikena Oncology Inc IKNA 465 11 2.28 -7.38 -581.21
Provention Bio Inc PRVB 399 1 3.08 -3.27 None
Rain Therapeutics Inc RAIN 350 413 2.42 -9.15 123.20
Chromadex Corp CDXC 299 65 8.71 -10.53 -42.83
Adicet Bio Inc ACET 279 10 1.52 4.84 -570.14
Verrica Pharmaceuticals Inc VRCA 241 12 6.26 -6.30 -320.98
Evolus Inc EOLS 239 86 3.10 -1.40 -162.78
Milestone Pharmaceuticals Inc MIST 231 15 1.32 -7.52 -230.90
Aquestive Therapeutics Inc AQST 194 47 -3.59 -3.11 -132.11
Terns Pharmaceuticals Inc TERN 193 1.13 -5.54 None
Cognition Therapeutics Inc CGTX 185 -2.24 -15.75 None
Opiant Pharmaceuticals Inc OPNT 150 44 3.37 120.00 3.58
Anebulo Pharmaceuticals Inc ANEB 149 7.62 -3.81 None
Citius Pharmaceuticals Inc CTXR 134 1.68 -5.85 None
Kaleido Biosciences Inc KLDO 132 1 4.80 -1.48 None
Xeris Biopharma Holdings Inc XERS 124 35 -100.00 -1.36 -265.78
scPharmaceuticals Inc SCPH 115 119 1.85 -4.10 -27.05
Kala Pharmaceuticals Inc KALA 107 12 1.84 -0.85 None
LifeMD Inc LFMD 107 78 -6.93 -0.96 -95.77
Aerpio Pharmaceuticals Inc ARPO 99 15 2.98 -5.24 -28.77
Eyenovia Inc EYEN 94 6 24.00 -4.74 -332.81
Eton Pharmaceuticals Inc ETON 92 16 5.75 -8.36 -67.52
Natural Alternatives Internati NAII 78 177 0.97 6.99 6.64
Osmotica Pharmaceuticals Plc OSMT 76 166 1.83 -0.75 -60.32
Mannatech Inc MTEX 70 159 2.68 9.09 5.00
Odonate Therapeutics Inc ODT 58 0.83 -0.57 None
India Globalization Capital In IGC 58 0 2.05 -5.00 -981.18
Context Therapeutics Inc CNTX 57 -2.81 -8.19 None
Assertio Holdings Inc ASRT 55 108 0.65 -1.32 -28.04
Shineco Inc SISI 55 3 2.23 -1.07 None
VYNE Therapeutics Inc VYNE 46 17 0.85 -0.83 -507.13
Shineco Inc TYHT 44 3 2.17 -1.55 -159.60
Reviva Pharmaceuticals Holding RVPH 39 1.52 -4.50 None
Acasti Pharma Inc ACST 29 0 0.47 -2.16 -611.47
Bio-Path Holdings Inc BPTH 25 0 1.02 -2.73 18.96
Nabriva Therapeutics Plc NBRV 23 20 0.63 -0.37 -266.57
Baudax Bio Inc BXRX 21 1 -1.35 -0.45 9.10
Cyanotech Corp. CYAN 21 35 1.15 10.12 6.09
Lexaria Bioscience Corp LEXX 20 1 2.76 -5.10 -445.15
Dermata Therapeutics Inc DRMA 20 0.45 -2.46 None
Trevi Therapeutics Inc TRVI 19 2.16 -0.54 None
Hoth Therapeutics Inc HOTH 16 1.45 -1.50 None
Timber Pharmaceuticals Inc TMBR 13 0 11.00 3.07 -527.55
Sonoma Pharmaceuticals Inc. SNOA 9 17 3.02 -1.72 -31.96

Xeris Biopharma Holdings Inc. (NASDAQ:XERS) Jumps 2.56%, But Further Rally Could Be Imminent

3h ago, source: marketingsentinel

In last trading session, Xeris Biopharma Holdings Inc. (NASDAQ:XERS) saw 1.19 million shares changing hands with its beta currently measuring 1.66. Company’s recent per share price level of $2.00 ...

Analyst Updating Price Targets And Ratings For Xeris Biopharma Holdings Inc. (XERS)

2h ago, source: stocksregister

Xeris Biopharma Holdings Inc. (NASDAQ:XERS) at last check was buoying at $2.01 on Friday, December 03, with a rise of 0.50% from its closing price on previous day. Taking a look at stock we notice ...

Xeris Biopharma Holdings Inc. (XERS) Is Another Fantastic Bargain Stock

3d ago, source: marketingsentinel

Xeris Biopharma Holdings Inc. (NASDAQ:XERS) has a beta value of 1.66 and has seen 1.44 million shares traded in the last trading session. The company, currently valued at $267.89M, closed the last ...

Xeris Biopharma Holdings Inc. (XERS) and the Battle of Fundamentals vs. Technicals

3d ago, source: newsheater

Xeris Biopharma Holdings Inc. (NASDAQ:XERS) went down by -5.99% from its latest closing price compared to the recent 1-year high of $7.94. The company’s stock price has collected -10.13% of loss in ...

Analysts Advise You To Maintain Your Position In Xeris Biopharma Holdings Inc. (NASDAQ: XERS)

3d ago, source: stocksregister

Xeris Biopharma Holdings Inc. (NASDAQ:XERS) traded at $2.12 at last check on Tuesday, November 30, made an upward move of 3.68% on its previous day’s price. Looking at the stock we see that its ...

Xeris Biopharma Holdings, Inc. (XERS) CEO Paul Edick on Q3 2021 Results - Earnings Call Transcript

23d ago, source: Seeking Alpha

Welcome to the Xeris Biopharma Third Quarter 2021 Financial Results Call. My name is Ruby and I will be your moderator for today’s call. [Operator Instructions] I will now hand over to your host ...

Xeris Biopharma Reports Third Quarter 2021 Financial Results and Other Highlights

23d ago, source: MarketWatch

CHICAGO, (BUSINESS WIRE) -- Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a biopharmaceutical company developing and commercializing unique therapies for patient populations in endocrinology ...

Xeris Biopharma Holdings Inc.

7d ago, source: Barron's

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Northern Trust Corp Sells 365,760 Shares of Xeris Pharmaceuticals, Inc. (NASDAQ:XERS)

2d ago, source: ETF Daily News

4.01% of the stock is owned by corporate insiders. Xeris Biopharma Holdings, Inc is a holding company. It offers a novel formulation technology to bring ready-to-use, liquid-stable injectable to ...

Xeris Pharmaceuticals Inc (XERS)

3d ago, source: Investing.com

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and ...

Your Portfolio